MedTrace Logo

Peripheral Artery Occlusive Diseases (PAOD) Study - Clinical Assessment

NCT00771797 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2015-09-23

No results posted yet for this study

Summary

To assess the clinical efficacy and to simultaneously explore the underlying molecular mechanisms of the beneficial effects of flavanol-rich cocoa on vascular function diabetic patients with peripheral artery occlusive diseases (PAOD) of the lower extremities will be investigated.

Conditions

Interventions

DIETARY_SUPPLEMENT

high dose flavanoids

flavanoid rich cocoa 2 times daily over 60 days

DIETARY_SUPPLEMENT

low dose flavanoids

treatment with flavanoid-low cocoa two times daily over 60 days

Sponsors & Collaborators

  • Heinrich-Heine University, Duesseldorf

    collaborator OTHER

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Tienush Rassaf, MD · Clinic for Cardiology, University Düsseldorf

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00771797 on ClinicalTrials.gov